Tuesday, 27 March 2018

28 Mar, Morning Brief

Market may open on a negative to flat note today as Asian markets are trading down after US markets declined yesterday because of tech stocks were hampered. Global markets fueled to gain yesterday and as a result Nifty inched near 10200 mark. Today is the last trading day of the financial year and also the derivative expiry of the month hence market may be volatile.

IPO Updates :

IPO subscribed 44 % on day 2.

🎯 News & Impact 🎯

🎯 Hindustan Aeronautics -
Listing Today.

🎯 Lupin : It has received US FDA nod for generic of Clobex Spray.
Positive for the stock. 👍

🎯 Biocon :
Mylan and Biocon receive approvals from the European Commission.

🎯 JMC Projects :
Company secures new orders worth Rs. 634 crore.

🎯 Dilip Buildcon :
Company incorporates new SPV to undertake six laning project in Andhra Pradesh.

🎯 Fortis :
Board approves demerger of its hospital business.

🎯 REC :
Company transfers transmission arm to PowerGrid.

🎯 KEC International :
Company's Saudi Arabia JV becomes its subsidiary.

🎯 Capital First :
Company to raise Rs.1,500-cr via bonds to fund business growth.

🎯 Reliance :
Reliance arm sells assets in Eagle Ford shale for USD 100 mn.

🎯 Rcom :
Sistema Shyam reduces stake in Rcom to 7 %.

🎯 Wipro :
Company launches tech centre in Texas, to raise headcount to 2,000

🎯 Tejas Network :
The company has won an expansion order of Rs.336 crore from BSNL for BharatNet.

🎯 SBI :
The bank is mulling possibility of merging SBI Card JV entities with itself.

🎯 Dena Bank :
Gets shareholders' nod for issue of shares worth Rs.3,045 crore to the government.

🎯 Maruti :
New Swift has clocked over 1 lakh bookings in 10 weeks - Hindu.

🎯 Ashok Leyland :
It will be increasing vehicle prices by at least 2% from April.

🎯 UltraTech :
Binani lenders agree to weigh UltraTech offer.

🎯 GSK :
Company looks to sell stake in Indian unit, puts Horlicks on the book.

🎯 Monnet Ispat :
ICICI Bank moved to NCLT to include USD 75 mn claim in Monnet Ispat insolvency case.

Edited by Sharp.
© 2018 Sharp Investment & Financial Advisers

No comments:

Post a Comment